{
  "id": 6473673,
  "title": "Artisan Sold Insulet (PODD) Due to Competition Concerns",
  "url": "https://urgent.news/2026/09/08/artisan-sold-insulet-podd-due-to-competition-concerns",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T13:00:10.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/markets/stocks/articles/artisan-sold-insulet-podd-due-130010972.html"
  },
  "original_language": "en",
  "account": "Artisan Partners decided to divest from Insulet Corporation (NASDAQ:PODD) in its second-quarter 2026 investor letter, citing growing competition in the insulin pump market. Insulet Corporation is a leading American medical device company known for its Omnipod insulin delivery system, which offers a tubeless automated insulin delivery system. The company benefits from strong patient adoption, expanding penetration in the type 2 diabetes market, and its pharmacy-based distribution model. The fund's investment in Insulet Corporation resulted in a strong performance in Q2 2026, with the fund returning 17.86% compared to the 14.55% gain for the Russell Midcap® Growth Index. The fund's decision to sell its stake in Insulet Corporation will be allocated to higher conviction opportunities.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}